ArticleEJHaem2020

A pilot clinical phase II trial MemSID: Acute and durable changes of red blood cells of sickle cell disease patients on memantine treatment.

Asya Mahkro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.